The histone acetyltransferase hMOF is frequently downregulated in primary breast carcinoma and medulloblastoma and constitutes a biomarker for clinical outcome in medulloblastoma (Q46866555)
Jump to navigation
Jump to search
scientific article published in March 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The histone acetyltransferase hMOF is frequently downregulated in primary breast carcinoma and medulloblastoma and constitutes a biomarker for clinical outcome in medulloblastoma |
scientific article published in March 2008 |
Statements
1 reference
The histone acetyltransferase hMOF is frequently downregulated in primary breast carcinoma and medulloblastoma and constitutes a biomarker for clinical outcome in medulloblastoma (English)
1 reference
1 reference
1 reference
1 reference
Peter Lichter
1 reference
Carina Ittrich
1 reference
Frank Mendrzyk
1 reference
Olaf Thuerigen
1 reference
Asifa Akhtar
1 reference
1 March 2008
1 reference
1 reference
122
1 reference
1207-1213
1 reference
6
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference